Recent News
May 13, 2026 — A shareholder lawsuit investigation and investor alerts by plaintiff firms followed disclosure of guidance cuts and a revenue miss. May 12, 2026 — Company presented at the Bank of America Global Healthcare Conference. Early May filings show an insider open-market purchase on May 4, 2026 and subsequent institutional item filings.
Technical Analysis
ADX stands at 43.38, indicating very strong trend strength; that strength magnifies the immediate price bias and raises the importance of directional signals when assessing near-term moves.
DI+ at 15.54 shows a dip & reversal while DI‑ at 41.55 shows a peak & reversal; both trend notes imply a shift toward stronger upside pressure from the directional indicators and therefore support the possibility of a short-term bullish regime change relative to recent price action.
MACD sits at -1.85 with a dip & reversal and the MACD line recently crossed above its signal line at -1.96; that bullish MACD cross signals rising momentum despite the negative absolute MACD level, and it supports a near-term positive price bias.
MRO reads -41.16 with a dip & reversal; the negative MRO indicates price lies below WMDST’s target and implies sizable upside potential toward valuation convergence if momentum continues.
RSI at 37.08 with a dip & reversal places the stock near the short-term oversold band; the rising RSI trend favors relief rallies but still leaves room for resistance on strength.
Price sits above the 20-day average ($20.40) yet below the 50-day ($25.98) and 200-day ($29.30) averages; short-term moving averages support a bounce while longer-term averages mark material overhead resistance. Bollinger bands show the stock trading near the upper 2× band, implying high intraday dispersion and swing risk. SuperTrend lower support near $18.91 establishes a nearer-term downside reference for momentum-driven moves.
Fundamental Analysis
Total revenue reached $1,350,654,000 with YoY revenue growth of 6.84% and a QoQ decline of -4.69%, indicating sequential softness despite annual expansion. Gross profit totaled $262,014,000 and gross margin registered 19.40% (YoY -1.70% QoQ +0.49%).
EBIT measured $74,307,000 and EBITDA $89,962,000, producing an EBIT margin of 5.50% (QoQ -14.45%, YoY -4.50%). That EBIT margin sits below the industry peer mean of 7.51% yet above the industry peer median of 4.69%, signaling middling operating efficiency versus peers while lagging the mean.
EPS came in at $0.40 versus an estimate of $0.37, producing an EPS surprise of 8.11%. Forward EPS of $0.513 and forward PE of 59.68 contrast with a trailing PE of 102.45, reflecting elevated current valuation versus expected near-term earnings.
Cash flow shows stress: free cash flow totaled $-21,156,000 and free cash flow yield equaled -0.45%, while operating cash flow registered $-12,110,000. Net debt stands at $982,499,000 and debt-to-EBITDA reads 14.12, indicating leveraged rent on earnings power despite an interest coverage ratio of 5.59 that maintains debt service headroom.
Liquidity metrics remain adequate: cash and short-term investments total $177,321,000, current ratio equals 1.64, and quick ratio equals 1.07. Asset turnover sits at 0.395, and return on equity equals 3.36% (QoQ decline noted), underscoring modest capital efficiency.
WMDST values the stock as over-valued. That valuation assessment, combined with negative free cash flow and a high debt-to-EBITDA multiple, implies fundamental risk that requires material operational improvement or earnings acceleration to justify current multiples.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-03-31 |
| REPORT DATE: | 2026-04-30 |
| NEXT REPORT DATE: | 2026-07-30 |
| CASH FLOW | Begin Period Cash Flow | $ 232.6 M |
| Operating Cash Flow | $ -12.11 M | |
| Capital Expenditures | $ -9.05 M | |
| Change In Working Capital | $ -89.73 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ -55.30 M | |
| End Period Cash Flow | $ 177.3 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 1.4 B | |
| Forward Revenue | $ 600.2 M | |
| COSTS | ||
| Cost Of Revenue | $ 1.1 B | |
| Depreciation | $ 15.7 M | |
| Depreciation and Amortization | $ 15.7 M | |
| Research and Development | — | |
| Total Operating Expenses | $ 1.3 B | |
| PROFITABILITY | ||
| Gross Profit | $ 262.0 M | |
| EBITDA | $ 90.0 M | |
| EBIT | $ 74.3 M | |
| Operating Income | $ 72.5 M | |
| Interest Income | — | |
| Interest Expense | $ 13.3 M | |
| Net Interest Income | $ -13.30 M | |
| Income Before Tax | $ 61.0 M | |
| Tax Provision | $ 15.7 M | |
| Tax Rate | 25.7 % | |
| Net Income | $ 45.3 M | |
| Net Income From Continuing Operations | $ 45.3 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.37 | |
| EPS Actual | $ 0.40 | |
| EPS Difference | $ 0.03 | |
| EPS Surprise | 8.108 % | |
| Forward EPS | $ 0.51 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 3.4 B | |
| Intangible Assets | $ 1.9 B | |
| Net Tangible Assets | $ -555.58 M | |
| Total Current Assets | $ 1.2 B | |
| Cash and Short-Term Investments | $ 177.3 M | |
| Cash | $ 177.3 M | |
| Net Receivables | $ 516.4 M | |
| Inventory | $ 415.7 M | |
| Long-Term Investments | $ 48.6 M | |
| LIABILITIES | ||
| Accounts Payable | $ 545.0 M | |
| Short-Term Debt | $ 6.8 M | |
| Total Current Liabilities | $ 729.7 M | |
| Net Debt | $ 982.5 M | |
| Total Debt | $ 1.3 B | |
| Total Liabilities | $ 2.0 B | |
| EQUITY | ||
| Total Equity | $ 1.4 B | |
| Retained Earnings | $ 922.3 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 8.61 | |
| Shares Outstanding | 156.988 M | |
| Revenue Per-Share | $ 8.60 | |
| VALUATION | Market Capitalization | $ 4.7 B |
| Enterprise Value | $ 5.8 B | |
| Enterprise Multiple | 63.993 | |
| Enterprise Multiple QoQ | 17.279 % | |
| Enterprise Multiple YoY | -5.48 % | |
| Enterprise Multiple IPRWA | high: 232.675 OPCH: 63.993 mean: 45.188 median: 33.809 low: -110.357 |
|
| EV/R | 4.262 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.502 | |
| Asset To Liability | 1.666 | |
| Debt To Capital | 0.485 | |
| Debt To Assets | 0.376 | |
| Debt To Assets QoQ | 1.984 % | |
| Debt To Assets YoY | 1.661 % | |
| Debt To Assets IPRWA | high: 1.218 OPCH: 0.376 mean: 0.329 median: 0.31 low: 0.005 |
|
| Debt To Equity | 0.94 | |
| Debt To Equity QoQ | -2.072 % | |
| Debt To Equity YoY | 3.842 % | |
| Debt To Equity IPRWA | high: 2.582 mean: 1.078 median: 1.011 OPCH: 0.94 low: -2.227 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 3.452 | |
| Price To Book QoQ | -12.123 % | |
| Price To Book YoY | -11.271 % | |
| Price To Book IPRWA | high: 13.088 OPCH: 3.452 mean: 2.568 median: 1.301 low: -1.067 |
|
| Price To Earnings (P/E) | 102.448 | |
| Price To Earnings QoQ | 14.11 % | |
| Price To Earnings YoY | -10.628 % | |
| Price To Earnings IPRWA | high: 167.375 OPCH: 102.448 mean: 37.498 median: 30.133 low: -277.995 |
|
| PE/G Ratio | -2.772 | |
| Price To Sales (P/S) | 3.453 | |
| Price To Sales QoQ | -2.88 % | |
| Price To Sales YoY | -12.417 % | |
| Price To Sales IPRWA | high: 21.195 mean: 4.896 OPCH: 3.453 median: 2.489 low: 0.026 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 59.675 | |
| Forward PE/G | -1.615 | |
| Forward P/S | 7.635 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | 2.701 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.395 | |
| Asset Turnover Ratio QoQ | -6.489 % | |
| Asset Turnover Ratio YoY | -0.237 % | |
| Asset Turnover Ratio IPRWA | high: 1.21 median: 0.397 OPCH: 0.395 mean: 0.349 low: 0.001 |
|
| Receivables Turnover | 2.729 | |
| Receivables Turnover Ratio QoQ | -11.737 % | |
| Receivables Turnover Ratio YoY | -9.279 % | |
| Receivables Turnover Ratio IPRWA | high: 10.101 median: 4.653 mean: 4.213 OPCH: 2.729 low: 0.809 |
|
| Inventory Turnover | 2.455 | |
| Inventory Turnover Ratio QoQ | -7.937 % | |
| Inventory Turnover Ratio YoY | -13.128 % | |
| Inventory Turnover Ratio IPRWA | high: 9.435 mean: 5.122 median: 4.582 OPCH: 2.455 low: 0.718 |
|
| Days Sales Outstanding (DSO) | 33.442 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 21.944 | |
| Cash Conversion Cycle Days QoQ | 50.658 % | |
| Cash Conversion Cycle Days YoY | 55.057 % | |
| Cash Conversion Cycle Days IPRWA | high: 90.31 OPCH: 21.944 median: 17.779 mean: 17.293 low: -62.922 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 2.902 | |
| CapEx To Revenue | -0.007 | |
| CapEx To Depreciation | -0.578 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 2.5 B | |
| Net Invested Capital | $ 2.5 B | |
| Invested Capital | $ 2.5 B | |
| Net Tangible Assets | $ -555.58 M | |
| Net Working Capital | $ 465.4 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.243 | |
| Current Ratio | 1.638 | |
| Current Ratio QoQ | 7.372 % | |
| Current Ratio YoY | 6.312 % | |
| Current Ratio IPRWA | high: 6.745 OPCH: 1.638 mean: 1.243 median: 0.866 low: 0.328 |
|
| Quick Ratio | 1.068 | |
| Quick Ratio QoQ | 11.587 % | |
| Quick Ratio YoY | 4.368 % | |
| Quick Ratio IPRWA | high: 6.531 OPCH: 1.068 mean: 1.032 median: 0.66 low: 0.365 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 14.119 | |
| Cost Of Debt | 0.778 % | |
| Interest Coverage Ratio | 5.585 | |
| Interest Coverage Ratio QoQ | -24.538 % | |
| Interest Coverage Ratio YoY | -3.761 % | |
| Interest Coverage Ratio IPRWA | high: 50.112 median: 6.088 OPCH: 5.585 mean: 4.505 low: -86.056 |
|
| Operating Cash Flow Ratio | -0.029 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 45.714 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | -2.19 % | |
| Revenue Growth | -7.833 % | |
| Revenue Growth QoQ | -469.307 % | |
| Revenue Growth YoY | 684.084 % | |
| Revenue Growth IPRWA | high: 31.112 % mean: 0.361 % median: -4.48 % OPCH: -7.833 % low: -15.485 % |
|
| Earnings Growth | -36.957 % | |
| Earnings Growth QoQ | -336.525 % | |
| Earnings Growth YoY | 84.785 % | |
| Earnings Growth IPRWA | high: 200.0 % mean: 54.717 % median: 4.423 % OPCH: -36.957 % low: -325.0 % |
|
| MARGINS | ||
| Gross Margin | 19.399 % | |
| Gross Margin QoQ | 0.487 % | |
| Gross Margin YoY | -1.698 % | |
| Gross Margin IPRWA | high: 88.188 % mean: 25.972 % median: 25.288 % OPCH: 19.399 % low: -15.298 % |
|
| EBIT Margin | 5.502 % | |
| EBIT Margin QoQ | -14.446 % | |
| EBIT Margin YoY | -4.496 % | |
| EBIT Margin IPRWA | high: 42.75 % mean: 7.513 % OPCH: 5.502 % median: 4.692 % low: -36.494 % |
|
| Return On Sales (ROS) | 5.371 % | |
| Return On Sales QoQ | -13.981 % | |
| Return On Sales YoY | -6.77 % | |
| Return On Sales IPRWA | high: 38.866 % mean: 7.557 % OPCH: 5.371 % median: 4.66 % low: -48.669 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ -21.16 M | |
| Free Cash Flow Yield | -0.454 % | |
| Free Cash Flow Yield QoQ | -206.323 % | |
| Free Cash Flow Yield YoY | 43.671 % | |
| Free Cash Flow Yield IPRWA | high: 9.14 % median: 2.951 % mean: 2.153 % OPCH: -0.454 % low: -16.159 % |
|
| Free Cash Growth | -195.105 % | |
| Free Cash Growth QoQ | 135.293 % | |
| Free Cash Growth YoY | 18.729 % | |
| Free Cash Growth IPRWA | high: 422.536 % median: -12.478 % mean: -33.121 % OPCH: -195.105 % low: -582.609 % |
|
| Free Cash To Net Income | -0.467 | |
| Cash Flow Margin | -1.571 % | |
| Cash Flow To Earnings | -0.468 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.327 % | |
| Return On Assets QoQ | -21.34 % | |
| Return On Assets YoY | -4.464 % | |
| Return On Assets IPRWA | high: 7.175 % OPCH: 1.327 % mean: 1.198 % median: 1.162 % low: -12.627 % |
|
| Return On Capital Employed (ROCE) | 2.804 % | |
| Return On Equity (ROE) | 0.034 | |
| Return On Equity QoQ | -23.917 % | |
| Return On Equity YoY | -3.006 % | |
| Return On Equity IPRWA | high: 0.27 mean: 0.038 median: 0.038 OPCH: 0.034 low: -0.275 |
|
| DuPont ROE | 3.387 % | |
| Return On Invested Capital (ROIC) | 2.2 % | |
| Return On Invested Capital QoQ | -19.118 % | |
| Return On Invested Capital YoY | -4.056 % | |
| Return On Invested Capital IPRWA | high: 15.003 % median: 2.517 % OPCH: 2.2 % mean: 2.113 % low: -10.552 % |
|